RCKT FY 2025 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RCKTRocket Pharmaceuticals, Inc.

$572M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$11M

Operating Income

-$229M

Net Income

-$223M

EPS (Diluted)

$-2.01

Cash Flow

Operating Cash Flow

-$190M

Free Cash Flow

-$190M

Stock-Based Comp.

$37M

Balance Sheet

Total Assets

$330M

Total Liabilities

$53M

Stockholders' Equity

$277M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$11M	$0	—
Operating Income	-$229M	-$273M	+16.4%
Net Income	-$223M	-$259M	+13.8%